Metoprolol Sandoz (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart. By inhibiting these receptors, it decreases cyclic AMP production, which leads to a slower heart rate, reduced contractile force, and lower cardiac output. The overall effect is a reduction in blood pressure and myocardial oxygen demand.

The appropriate dose of Metoprolol Sandoz is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other concurrent medications. Dosage may be adjusted over time to achieve optimal blood‑pressure control or symptom relief.

Safety data for Metoprolol Tartrate in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their healthcare provider.

To request Metoprolol Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

Metoprolol Sandoz is a cardio‑selective β1‑blocker, offering a favorable profile for patients with hypertension or angina who require heart‑specific action. Compared with non‑selective agents such as propranolol, it has less impact on bronchial β2 receptors, reducing the risk of bronchospasm in patients with respiratory disease.

Metoprolol Sandoz tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metoprolol Sandoz is administered orally as a tablet. Patients should swallow the tablet whole with a glass of water, preferably at the same time each day. If a dose is missed, it should be taken as soon as remembered unless the next scheduled dose is near, in which case the missed dose is skipped.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in susceptible individuals, and worsening heart failure. Patients should be monitored for signs of these events, and the medication should be discontinued promptly if they occur.

Metoprolol Sandoz is contraindicated in patients with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block, cardiogenic shock, overt heart failure, and uncontrolled asthma or severe chronic obstructive pulmonary disease. Caution is also advised for individuals with severe peripheral vascular disease.